Kornitzer Capital Management Inc Ultragenyx Pharmaceutical Inc. Transaction History

Kornitzer Capital Management Inc

  • $5.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 31, 2019
SELL
$38.89 - $77.3 $2.26 Million - $4.49 Million
-58,125 Closed
0 $0
Q2 2018

Aug 02, 2018
SELL
$48.54 - $85.31 $688,539 - $1.21 Million
-14,185 Reduced 19.62%
58,125 $4.47 Million
Q1 2018

Apr 30, 2018
BUY
$44.33 - $58.52 $3.21 Million - $4.23 Million
72,310 New
72,310 $3.69 Million

Others Institutions Holding RARE

# of Institutions
326
Shares Held
85.7M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.27B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email